Officer Files Intent to Sell $466K in Shares Following Option Exercise
AVTX has more than doubled off its 52-week low of $3.39.
Summary
An officer of Avalo Therapeutics has filed a Form 144 to sell shares worth approximately $466,558, which were acquired through stock option exercises.
Key Events · Ownership and Investor Activity · AVTX
-
Officer Files Intent to Sell
Mittie Doyle, an officer of Avalo Therapeutics, Inc., has filed a Form 144 indicating an intent to sell 29,529 shares of common stock.
-
Value of Proposed Sale
The approximate market value of the shares intended for sale is $466,558.20.
-
Shares Acquired via Option Exercise
The shares to be sold were acquired through the exercise of stock options.
Analysis · AVTX · Life Sciences
Mittie Doyle, an officer of Avalo Therapeutics, Inc., has filed a Form 144 indicating an intent to sell approximately $466,558 worth of common stock. These shares were acquired through the exercise of stock options. While the sale provides liquidity for the officer, it represents a reduction in insider ownership and could be perceived negatively by investors, signaling a potential lack of confidence or a desire to diversify holdings.
How filings like this one have moved
In the 30 days to Sep 15, 2026, 29.9% of the 1678 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.25%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AVTX was trading at $16.02 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $296.6M. The 52-week trading range was $3.39 to $20.72. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.